Browsing Linhardt Research Labs Papers by Author "Walenga, Jeanine M."

Now showing items 1-3 of 3

Biological profile of hyper/oversulfated chondroitin sulfate contaminant isolated from recalled heparin

Fareed, Jawed; Walenga, Jeanine M.; Jeske, Walter P.; Hoppensteadt, Debra; Prechel, Margaret; Iqbal, Omer; Adiguzel, Cafer; Clark, Melanie; Litinas, Evangelos; Cunanan, Josephine; Linhardt, Robert; Harenberg, Job (2008-12-15)
Heparin Oligosaccharides as Potential Therapeutic Agents in Senile Dementia

Ma, Qing; Cornelli, Umberto; Hanin, Israel; Jeske, Walter P.; Linhardt, Robert J.; Walenga, Jeanine M.; Fareed, Jawed; Lee, John M. (Bentham Science, 2007-05-01)

Heparin is a glycosaminoglycan mixture currently used in prophylaxis and treatment of thrombosis. Heparin possesses non-anticoagulant properties, including modulation of various proteases, interactions with fibroblast ...
Heparinase I Acts on a Synthetic Heparin Pentasaccharide Corresponding to the Antithrombin III Binding Site

Yu, Guangli; LeBrun, Laurie; Gunay, Nur Sibel; Hoppensteadt, Debra; Walenga, Jeanine M.; Fareed, Jawed; Linhardt, Robert J. (2000-12-15)

A synthetic pentasaccharide, containing an intact antithrombin III (ATIII) binding site that is in clinical studies a specific antifactor Xa agent, serves as a substrate for a heparin lyase (heparinase I, EC 4.2.2.7) from ...